Eurasian Clinical and Analytical Medicine (ECAM) routinely discloses editorial metrics to promote transparency and research integrity. Below are the key statistics for the January 2025 and May 2025 issues, followed by the consolidated results for the year 2024.
Published articles: 5 (4 original research, 1 case report). None of the accepted articles were authored by editors or editorial board members.
Editorial timelines: Average acceptance time 47 days; average time from acceptance to print 15 days.
Published articles: 7 (5 original research, 1 case report, 1 review). None of the accepted articles were authored by editors or editorial board members.
Editorial timelines: Average acceptance time 40 days; average time from acceptance to print 28 days.
Submissions: 65 • Accepted & published: 20 • Acceptance rate: 31% • Rejection rate: 69%.
Peer-review duration: Average 14 days. Revisions: 72% single-round; 19% two or more rounds. Acceptance-to-print: Average 70 days.
Published article types: 14 original research, 3 case reports, 3 reviews. All articles underwent plagiarism screening and language editing. None of the accepted articles were authored by editors or editorial board members.
These data demonstrate ECAM's continued commitment to rigorous peer review, editorial independence, and transparent reporting—principles that uphold the scientific quality, reproducibility, and global credibility of the medical literature.
